Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 16, 2022

BUY
$242.49 - $301.46 $42,920 - $53,358
177 Added 5.23%
3,559 $874,000
Q2 2022

Aug 08, 2022

BUY
$224.73 - $338.64 $108,095 - $162,885
481 Added 16.58%
3,382 $837,000
Q1 2022

May 09, 2022

BUY
$277.25 - $366.29 $26,338 - $34,797
95 Added 3.39%
2,901 $961,000
Q4 2021

Feb 04, 2022

BUY
$300.63 - $371.35 $39,983 - $49,389
133 Added 4.98%
2,806 $1.01 Million
Q3 2021

Nov 17, 2021

BUY
$310.19 - $376.2 $10,856 - $13,167
35 Added 1.33%
2,673 $870,000
Q2 2021

Aug 12, 2021

SELL
$262.71 - $351.17 $29,160 - $38,979
-111 Reduced 4.04%
2,638 $823,000
Q1 2021

May 14, 2021

BUY
$285.92 - $355.13 $47,748 - $59,306
167 Added 6.47%
2,749 $876,000
Q4 2020

Feb 11, 2021

SELL
$251.88 - $324.2 $12,845 - $16,534
-51 Reduced 1.94%
2,582 $837,000
Q3 2020

Nov 12, 2020

BUY
$255.22 - $317.0 $33,178 - $41,210
130 Added 5.19%
2,633 $729,000
Q2 2020

Aug 12, 2020

SELL
$141.4 - $257.09 $82,153 - $149,369
-581 Reduced 18.84%
2,503 $605,000
Q1 2020

May 01, 2020

BUY
$130.51 - $196.01 $99,318 - $149,163
761 Added 32.76%
3,084 $448,000
Q4 2019

Feb 18, 2020

SELL
$159.31 - $223.54 $318 - $447
-2 Reduced 0.09%
2,323 $396,000
Q3 2019

Nov 05, 2019

BUY
$175.89 - $279.23 $39,399 - $62,547
224 Added 10.66%
2,325 $414,000
Q2 2019

Aug 07, 2019

BUY
$250.96 - $284.94 $32,624 - $37,042
130 Added 6.6%
2,101 $547,000
Q1 2019

May 22, 2019

BUY
$276.39 - $362.25 $3,316 - $4,347
12 Added 0.61%
1,971 $563,000
Q4 2018

Feb 25, 2019

BUY
$281.08 - $444.25 $13,491 - $21,324
48 Added 2.51%
1,959 $637,000
Q3 2018

Nov 19, 2018

BUY
$354.53 - $449.75 $677,506 - $859,472
1,911 New
1,911 $0
Q3 2018

Nov 16, 2018

SELL
$354.53 - $449.75 $636,026 - $806,851
-1,794 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$278.07 - $446.21 $498,857 - $800,500
1,794 New
1,794 $734,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Kentucky Retirement Systems Portfolio

Follow Kentucky Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.